Dihydropyridine Calcium Channel Blockers and Kidney Outcomes
ConclusionsDCCBs were associated with increased risk of albuminuria and, in the absence of RAS blockade, KFRT. These findings suggest coupling DCCB therapy with RAS blockade may mitigate adverse kidney outcomes.
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
More News: Calcium | Electronic Health Records (EHR) | Information Technology | Internal Medicine | Study | Urology & Nephrology